ST. LOUIS and DURHAM, N.C., Jan. 27 /PRNewswire-FirstCall/ -- As farmers look to get more out of each acre of farmland, St. Louis-based Monsanto (NYSE: MON) is exploring unique ways to discover and deliver more desirable traits through the seed. Monsanto's new collaboration with GrassRoots Biotechnology Inc. is expected to do just that by expanding the benefits of Monsanto's research and product portfolio for its farmer customer.
Today, Monsanto announced that it has established a three-year collaboration with GrassRoots Biotechnology Inc., based in Research Triangle Park, North Carolina, to source novel genetic elements, including promoters and genes, which can enable crops to express traits that enhance and protect yield.
Promoters are segments of DNA that determine when and where a trait is expressed within a plant. Monsanto will use the promoters sourced from GrassRoots in a broad range of crops, including corn, soy, cotton and canola, to optimize an array of biotechnology traits.
GrassRoots is a start-up company co-founded by
"The availability of high-quality promoters with specific expression patterns for use in commercial products is limited, so there is value in developing novel promoters to drive new traits," said Steve Padgette, vice president of biotechnology for Monsanto.
"A robust promoter toolbox can further leverage Monsanto's extensive gene library and lead to the development of more biotechnology-based crop products with a greater number of characteristics such as higher yield, and tolerance to insects, weeds and other stresses," Padgette said.
Such tools will be critical in helping Monsanto meet its sustainability goal of doubling yields in core crops by 2030, he said.
"We will need to use the best technologies available to maximize the potential of these crops," Padgette said.
Another goal of the collaboration is to identify genes that help plants fight environmental stresses such as nitrogen deficiency. The collaboration is expected to build upon Monsanto's research philosophy of developing valuable families of technologies for the challenges farmers routinely face on farm.
"We are excited to form an alliance with Monsanto," said Philip Benfey, president and chief executive of GrassRoots. "Our technologies and expertise combined with Monsanto's commercialization pipeline will provide a means of rapidly moving new genes and promoters into the field."
About Monsanto Company
Monsanto Company is a leading global provider of technology-based solutions and agricultural products that improve farm productivity and food quality. Monsanto remains focused on enabling both small-holder and large- scale farmers to produce more from their land while conserving more of our world's natural resources such as water and energy. To learn more about our business and our commitments, please visit: www.monsanto.com .
About GrassRoots Biotechnology
GrassRoots Biotechnology, Inc. is a start-up company based in Research
Triangle Park, NC. The company was founded to advance and commercialize
technologies developed by co-founder Dr. Philip Benfey in his laboratory at
GrassRoots also is developing an energy program to create enhanced biofuel crops. Independently, GrassRoots is developing a bioenergy research program. The company is creating enhanced biofuel feedstocks with increased biomass, more accessible cellulose to facilitate processing, and roots that sequester greater amounts of carbon.
Certain statements contained in this press release are forward-looking statements, such as statements concerning the company's future product performance, regulatory approvals, business and financial plans and other non- historical facts. These statements are based on current expectations and currently available information. However, since these statements are based on factors that involve risks and uncertainties, the company's actual performance and results may differ materially from those described or implied by such forward-looking statements. Factors that could cause or contribute to such differences include, among others: the success of the companies' research and development activities; the costs of and the companies' abilities to access and enforce intellectual property needed for the collaboration; the costs and requirements of regulatory compliance and the speed with which approvals are received; public acceptance of biotechnology products; and other risks and factors detailed in the company's most recent periodic report to the SEC. Undue reliance should not be placed on these forward-looking statements, which are current only as of the date of this presentation. The company disclaims any current intention or obligation to update any forward-looking statements or any of the factors that may affect actual results.
|SOURCE Monsanto Company|
Copyright©2009 PR Newswire.
All rights reserved